305 related articles for article (PubMed ID: 25941598)
21. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy.
Ghazawi FM; Netchiporouk E; Rahme E; Tsang M; Moreau L; Glassman S; Provost N; Gilbert M; Jean SE; Pehr K; Sasseville D; Litvinov IV
Cancer; 2017 Sep; 123(18):3550-3567. PubMed ID: 28493286
[TBL] [Abstract][Full Text] [Related]
22. TOX Expression in Mycosis Fungoides and Sezary Syndrome.
Pileri A; Cavicchi M; Bertuzzi C; Righi S; Zengarini C; Sabattini E; Roncador G; Agostinelli C
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885488
[TBL] [Abstract][Full Text] [Related]
23. Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma.
Huang Y; Su MW; Jiang X; Zhou Y
Blood; 2015 Feb; 125(9):1435-43. PubMed ID: 25548321
[TBL] [Abstract][Full Text] [Related]
24. Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis.
Hu T; Krejsgaard T; Nastasi C; Buus TB; Nansen A; Hald A; Spee P; Nielsen PR; Blümel E; Gluud M; Willerslev-Olsen A; Woetmann A; Bzorek M; Eriksen JO; Ødum N; Rahbek Gjerdrum LM
Dermatology; 2020; 236(2):123-132. PubMed ID: 31536992
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
26. Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma.
Ion A; Popa IM; Papagheorghe LM; Lisievici C; Lupu M; Voiculescu V; Caruntu C; Boda D
Dis Markers; 2016; 2016():9602472. PubMed ID: 27821903
[TBL] [Abstract][Full Text] [Related]
27. miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma.
McGirt LY; Adams CM; Baerenwald DA; Zwerner JP; Zic JA; Eischen CM
J Invest Dermatol; 2014 Apr; 134(4):1101-1107. PubMed ID: 24304814
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients.
Lefrançois P; Xie P; Wang L; Tetzlaff MT; Moreau L; Watters AK; Netchiporouk E; Provost N; Gilbert M; Ni X; Sasseville D; Wheeler DA; Duvic M; Litvinov IV
Oncoimmunology; 2018; 7(8):e1467856. PubMed ID: 30221071
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
30. T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin.
Potoczna N; Boehncke WH; Nestle FO; Küenzlen C; Sterry W; Burg G; Dummer R
J Cutan Pathol; 1996 Aug; 23(4):298-305. PubMed ID: 8864915
[TBL] [Abstract][Full Text] [Related]
31. Malignant and Benign T Cells Constituting Cutaneous T-Cell Lymphoma.
Nakai S; Kiyohara E; Watanabe R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884736
[TBL] [Abstract][Full Text] [Related]
32. Serum and cutaneous transcriptional expression levels of IL31 are minimal in cutaneous T cell lymphoma variants.
van Santen S; Out JJ; Zoutman WH; Quint KD; Willemze R; Vermeer MH; Tensen CP
Biochem Biophys Rep; 2021 Jul; 26():101007. PubMed ID: 34027133
[TBL] [Abstract][Full Text] [Related]
33. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
[TBL] [Abstract][Full Text] [Related]
34. Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome
Netchiporouk E; Gantchev J; Tsang M; Thibault P; Watters AK; Hughes JM; Ghazawi FM; Woetmann A; Ødum N; Sasseville D; Litvinov IV
Oncotarget; 2017 Nov; 8(56):95981-95998. PubMed ID: 29221181
[No Abstract] [Full Text] [Related]
35. A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming.
Chan YS; Göke J; Lu X; Venkatesan N; Feng B; Su IH; Ng HH
Stem Cells; 2013 Apr; 31(4):682-92. PubMed ID: 23280602
[TBL] [Abstract][Full Text] [Related]
36. Deletion of Polycomb Repressive Complex 2 From Mouse Intestine Causes Loss of Stem Cells.
Koppens MA; Bounova G; Gargiulo G; Tanger E; Janssen H; Cornelissen-Steijger P; Blom M; Song JY; Wessels LF; van Lohuizen M
Gastroenterology; 2016 Oct; 151(4):684-697.e12. PubMed ID: 27342214
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
[TBL] [Abstract][Full Text] [Related]
38. mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy.
Knaneh J; Hodak E; Fedida-Metula S; Edri A; Eren R; Yoffe Y; Amitay-Laish I; Prag Naveh H; Lubin I; Porgador A; Moyal L
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686697
[No Abstract] [Full Text] [Related]
39. Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma.
Kamijo H; Miyagaki T; Shishido-Takahashi N; Nakajima R; Oka T; Suga H; Sugaya M; Sato S
Blood; 2018 Nov; 132(18):1922-1935. PubMed ID: 30194255
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the 2008 World Health Organization classification for non-mycosis fungoides, non-Sezary syndrome T/NK-cell lymphomas with primary cutaneous involvement.
Chang D; Zerbini MCN; Sotto MN; Siqueira SAC; Sanches JA
J Cutan Pathol; 2015 Dec; 42(12):965-973. PubMed ID: 26268415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]